Cas no 83724-17-8 (4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl-)
4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- Chemical and Physical Properties
Names and Identifiers
-
- 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl-
- 6-(dimethylamino)-2-methyl-1H-pyrimidin-4-one
- 4-(dimethylamino)-2-methyl-1H-pyrimidin-6-one
- SCHEMBL11190041
- 6-(Dimethylamino)-2-methylpyrimidin-4(1H)-one
- AD-0763
- CS-0330961
- AKOS005071794
- 6-(dimethylamino)-2-methyl-4-pyrimidinol
- SB55641
- DTXSID80608104
- 83724-17-8
- 6-(Dimethylamino)-2-methylpyrimidin-4(3H)-one
- 6-(dimethylamino)-2-methylpyrimidin-4-ol
- MFCD11840974
- AKOS030255560
-
- MDL: MFCD11840974
- Inchi: 1S/C7H11N3O/c1-5-8-6(10(2)3)4-7(11)9-5/h4H,1-3H3,(H,8,9,11)
- InChI Key: JCVFYJPZRHEZHB-UHFFFAOYSA-N
- SMILES: O=C1C=C(N=C(C)N1)N(C)C
Computed Properties
- Exact Mass: 153.090211983g/mol
- Monoisotopic Mass: 153.090211983g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 11
- Rotatable Bond Count: 1
- Complexity: 240
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: -0.4
- Topological Polar Surface Area: 44.7?2
4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046255-1g |
6-(Dimethylamino)-2-methyl-4-pyrimidinol |
83724-17-8 | >95% | 1g |
4941CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046255-500mg |
6-(Dimethylamino)-2-methyl-4-pyrimidinol |
83724-17-8 | >95% | 500mg |
3966CNY | 2021-05-07 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046255-1g |
6-(Dimethylamino)-2-methyl-4-pyrimidinol |
83724-17-8 | >95% | 1g |
4941.0CNY | 2021-07-05 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 046255-500mg |
6-(Dimethylamino)-2-methyl-4-pyrimidinol |
83724-17-8 | >95% | 500mg |
3966.0CNY | 2021-07-05 | |
| Chemenu | CM526026-1g |
6-(Dimethylamino)-2-methylpyrimidin-4(3H)-one |
83724-17-8 | 95% | 1g |
$153 | 2023-02-01 | |
| Apollo Scientific | OR33489-1g |
6-(Dimethylamino)-2-methylpyrimidin-4-ol |
83724-17-8 | 95% | 1g |
£231.00 | 2025-02-20 | |
| Apollo Scientific | OR33489-5g |
6-(Dimethylamino)-2-methylpyrimidin-4-ol |
83724-17-8 | 95% | 5g |
£890.00 | 2023-09-01 | |
| abcr | AB269055-500 mg |
6-(Dimethylamino)-2-methyl-4-pyrimidinol, 95%; . |
83724-17-8 | 95% | 500mg |
€215.40 | 2023-04-26 | |
| abcr | AB269055-1 g |
6-(Dimethylamino)-2-methyl-4-pyrimidinol, 95%; . |
83724-17-8 | 95% | 1g |
€315.00 | 2023-04-26 | |
| Matrix Scientific | 046255-1g |
6-(Dimethylamino)-2-methyl-4-pyrimidinol, >95% |
83724-17-8 | >95% | 1g |
$304.00 | 2023-09-06 |
4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- Related Literature
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
-
Thi Thu Tram Nguyen,Thanh Binh Nguyen Org. Biomol. Chem., 2021,19, 6015-6020
-
Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153
Additional information on 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl-
4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl-: A Comprehensive Overview
The compound with CAS No. 83724-17-8, commonly referred to as 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl-, is a significant molecule in the field of organic chemistry and pharmacology. This compound belongs to the class of pyrimidinones, which are heterocyclic aromatic compounds with a wide range of applications in drug discovery and material science. The pyrimidinone core structure is particularly interesting due to its ability to form hydrogen bonds and participate in various biochemical interactions, making it a valuable scaffold for medicinal chemists.
Recent studies have highlighted the potential of 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- as a lead compound in the development of new therapeutic agents. Researchers have explored its ability to modulate key biological targets, such as kinases and proteases, which are critical in diseases like cancer and neurodegenerative disorders. The dimethylamino group attached to the pyrimidinone ring contributes to the molecule's lipophilicity, enhancing its bioavailability and ability to penetrate cellular membranes. This property is particularly advantageous in drug design, where achieving the right balance between solubility and membrane permeability is essential.
The synthesis of 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- involves a multi-step process that typically begins with the preparation of a suitable pyrimidine derivative. One common approach is the cyclization of a diamine or diamide intermediate under specific conditions to form the pyrimidinone ring. The introduction of the dimethylamino and methyl substituents is carefully controlled to ensure high purity and yield. Recent advancements in catalytic methods and green chemistry have made this synthesis more efficient and environmentally friendly.
In terms of applications, 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- has shown promise in several areas beyond traditional pharmaceuticals. For instance, it has been investigated as a building block for advanced materials, such as organic semiconductors and stimuli-responsive polymers. Its unique electronic properties make it suitable for applications in optoelectronics and sensing technologies. Additionally, this compound has been used as a chiral auxiliary in asymmetric synthesis, demonstrating its versatility in organic chemistry.
One of the most exciting developments involving 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- is its role in targeted drug delivery systems. By incorporating this compound into nanoparticles or liposomes, researchers have achieved enhanced targeting of specific tissues or cells. This approach not only improves the efficacy of therapeutic agents but also reduces their systemic toxicity, which is a major concern in conventional chemotherapy.
Looking ahead, the continued exploration of 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- is expected to yield even more innovative applications. Collaborative efforts between academia and industry are likely to accelerate its translation from laboratory research to clinical use. As computational tools like machine learning and molecular docking become more sophisticated, the design of derivatives with improved pharmacokinetic profiles will become more efficient.
In conclusion, 4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl- (CAS No. 83724-17-8) stands out as a versatile and promising molecule with diverse applications across multiple disciplines. Its unique chemical properties, combined with recent advances in synthesis and application techniques, position it as a key player in future scientific breakthroughs.
83724-17-8 (4(1H)-Pyrimidinone, 6-(dimethylamino)-2-methyl-) Related Products
- 106660-22-4(4(1H)-Pyrimidinone, 6-(dodecylamino)-2-methyl-)
- 66487-64-7(4(1H)-Pyrimidinone, 6-(butylamino)-2-methyl-)
- 84292-19-3(2H-PYRIDO[1,2-A]PYRIMIDIN-2-ONE, 4-(ETHYLMETHYLAMINO)-)
- 24903-63-7(4(1H)-PYRIMIDINONE, 1,2-DIMETHYL-)
- 83718-00-7(5-methyl-Imidazo[1,2-c]pyrimidine-2,7(1H,3H)-dione)
- 773803-60-4(4(3H)-Pyrimidinone,5-amino-6-(dimethylamino)-2-methyl-)
- 1390654-76-8(6-amino-2-(2-aminoethyl)-4-pyrimidinol dihydrochloride)
- 84323-06-8(2H-PYRIDO[1,2-A]PYRIMIDIN-2-ONE, 4-(DIMETHYLAMINO)-)
- 24903-73-9(4(1H)-Pyrimidinone, 1-ethyl-2-methyl-)
- 84292-22-8(2H-Pyrido[1,2-a]pyrimidin-2-one, 4-(diethylamino)-)